Low‐dose combination of flutamide, metformin and an oral contraceptive for non‐obese, young women with polycystic ovary syndrome

By Ibáñez Lourdes  

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 57-60

Oxford University Press

Access to resources Recommend Favorite

Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment

By Kilic Sevtap   Yilmaz Nafiye   Zulfikaroglu Ebru   Erdogan Gokcen   Aydin Murat   Batioglu Sertac  

Gynecological Endocrinology, Vol. 27, Iss. 9, 2011-09 ,pp. : 622-629

Informa Healthcare

Access to resources Recommend Favorite

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome

By Yilmaz Murat   Bi˙ri˙ Aydan   Bukan Neslihan   Karakoç Ayhan   Sancak Banu   Törüner Füsun   Paşaoğlu Hatice  

Gynecological Endocrinology, Vol. 20, Iss. 5, 2005-05 ,pp. : 258-263

Informa Healthcare

Access to resources Recommend Favorite

Reproductive endocrinology. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome

By Eldar-Geva T.  

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2552-2556

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin

By Cibula D.  

Human Reproduction, Vol. 17, Iss. 1, 2002-01 ,pp. : 76-82

Oxford University Press

Access to resources Recommend Favorite